Free tool
FAERS Monitor: Cystadane
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020576 or its brand name (Cystadane, Betaine). Reports on generic versions are filed under their own applications.
Reports
1,045
Serious
656
63% of reports
Hospitalization
400
Death reported
74
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use149
- overdose86
- vomiting81
- diarrhoea64
- product dose omission55
- nausea48
- seizure43
- product use issue41
- pneumonia39
- product dose omission issue39
- pyrexia39
- inappropriate schedule of product administration37
- influenza35
- abdominal discomfort31
- treatment noncompliance30
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 2 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 5 |
| 2011 | 8 |
| 2012 | 24 |
| 2013 | 14 |
| 2014 | 35 |
| 2015 | 39 |
| 2016 | 85 |
| 2017 | 72 |
| 2018 | 83 |
| 2019 | 122 |
| 2020 | 123 |
| 2021 | 65 |
| 2022 | 84 |
| 2023 | 118 |
| 2024 | 64 |
| 2025 | 60 |
| 2026 | 31 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,114 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| product dose omissionSignal | 55 | 17.0 | 13.1 | 813 |
| treatment noncomplianceSignal | 30 | 11.0 | 7.8 | 265 |
| overdoseSignal | 86 | 8.0 | 6.6 | 527 |
| seizureSignal | 43 | 7.5 | 5.6 | 237 |
| influenzaSignal | 35 | 6.3 | 4.6 | 152 |
| product use issueSignal | 41 | 4.4 | 3.3 | 105 |
| inappropriate schedule of product administrationSignal | 37 | 4.1 | 3.0 | 85 |
| abdominal discomfortSignal | 31 | 3.7 | 2.6 | 59 |
| vomitingSignal | 81 | 3.5 | 2.8 | 143 |
| off label useSignal | 149 | 3.4 | 3.0 | 264 |
| product dose omission issueSignal | 39 | 2.7 | 2.0 | 40 |
| pneumoniaSignal | 39 | 2.4 | 1.8 | 32 |
| pyrexiaSignal | 39 | 2.3 | 1.7 | 27 |
| diarrhoea | 64 | 2.0 | 1.6 | 32 |
| nausea | 48 | 1.2 | 0.9 | 2 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.